- Home
- HOUR vs LUNG Comparison
HOUR vs LUNG Comparison
Compare HOUR & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- LUNG
- Stock Information
- Founded
- HOUR 2015
- LUNG 1995
- Country
- HOUR United States
- LUNG United States
- Employees
- HOUR N/A
- LUNG N/A
- Industry
- HOUR Catalog/Specialty Distribution
- LUNG Industrial Specialties
- Sector
- HOUR Consumer Discretionary
- LUNG Health Care
- Exchange
- HOUR Nasdaq
- LUNG Nasdaq
- Market Cap
- HOUR 63.3M
- LUNG 65.6M
- IPO Year
- HOUR 2022
- LUNG 2020
- Fundamental
- Price
- HOUR $1.52
- LUNG $1.76
- Analyst Decision
- HOUR
- LUNG Buy
- Analyst Count
- HOUR 0
- LUNG 7
- Target Price
- HOUR N/A
- LUNG $7.66
- AVG Volume (30 Days)
- HOUR 22.1K
- LUNG 915.9K
- Earning Date
- HOUR 08-12-2025
- LUNG 07-30-2025
- Dividend Yield
- HOUR N/A
- LUNG N/A
- EPS Growth
- HOUR N/A
- LUNG N/A
- EPS
- HOUR 0.02
- LUNG N/A
- Revenue
- HOUR $138,441,228.00
- LUNG $90,549,000.00
- Revenue This Year
- HOUR N/A
- LUNG $10.30
- Revenue Next Year
- HOUR N/A
- LUNG $14.72
- P/E Ratio
- HOUR $67.34
- LUNG N/A
- Revenue Growth
- HOUR N/A
- LUNG 18.24
- 52 Week Low
- HOUR $1.10
- LUNG $1.47
- 52 Week High
- HOUR $6.90
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- HOUR 37.65
- LUNG 42.85
- Support Level
- HOUR $1.46
- LUNG $1.62
- Resistance Level
- HOUR $1.60
- LUNG $1.83
- Average True Range (ATR)
- HOUR 0.09
- LUNG 0.12
- MACD
- HOUR -0.04
- LUNG 0.07
- Stochastic Oscillator
- HOUR 12.88
- LUNG 69.05
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.